Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

ImmunityBio (IBRX) Shares Repurchased: 2016-2019

Historic Shares Repurchased for ImmunityBio (IBRX) over the last 2 years, with Dec 2019 value amounting to $2.0 million.

  • ImmunityBio's Shares Repurchased rose 777.19% to $2.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $16.4 million, marking a year-over-year increase of 6.15%. This contributed to the annual value of $2.5 million for FY2019, which is 996.93% up from last year.
  • Per ImmunityBio's latest filing, its Shares Repurchased stood at $2.0 million for Q4 2019, which was up 777.19% from $228,000 recorded in Q4 2018.
  • ImmunityBio's Shares Repurchased's 5-year high stood at $11.4 million during Q2 2017, with a 5-year trough of $228,000 in Q4 2018.
  • Its 3-year average for Shares Repurchased is $3.5 million, with a median of $2.0 million in 2019.
  • As far as peak fluctuations go, ImmunityBio's Shares Repurchased tumbled by 91.77% in 2018, and later skyrocketed by 777.19% in 2019.
  • Over the past 4 years, ImmunityBio's Shares Repurchased (Quarterly) stood at $3.9 million in 2016, then decreased by 29.83% to $2.8 million in 2017, then plummeted by 91.77% to $228,000 in 2018, then skyrocketed by 777.19% to $2.0 million in 2019.
  • Its last three reported values are $2.0 million in Q4 2019, $228,000 for Q4 2018, and $2.8 million during Q4 2017.